Monsanto, Teresita M.
HRN: 06-99-94 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2024
CEFTRIAXONE 1G (VIAL)
08/10/2024
08/17/2024
IV
2g
Q24h
Complicated UTI
Waiting Final Action